Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of General Virology|March 1, 1996
Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drugA M Borman, S Paulous, F ClavelAIDS (London, England)|November 5, 1999
Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapiesE Race, E Dam, V Obry, et al.Journal of Virology|October 1, 1993
Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusionR Keller, K Peden, S Paulous, et al.Molecular and Cellular Biology|June 8, 2001
Eukaryotic initiation factor 4G-poly(A) binding protein interaction is required for poly(A) tail-mediated stimulation of picornavirus internal ribosome entry segment-driven translation but not for X-mediated stimulation of hepatitis C virus translationY M Michel, A M Borman, S Paulous, et al.The Journal of General Virology|July 1, 1992
Functional mapping of the rev-responsive element of human immunodeficiency virus type 2 (HIV-2): influence of HIV-2 envelope-encoding sequences on HIV-1 gp120 expression in the presence or absence of RevS Paulous, M Emerman, R Keller, et al.Journal of Virology|April 3, 1998
Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivoV Zennou, F Mammano, S Paulous, et al.Journal of Molecular Biology|September 2, 1994
HIV-1 reverse transcription. A termination step at the center of the genomeP Charneau, G Mirambeau, P Roux, et al.Journal of Virology|March 12, 1999
Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivityL C de la Carrière, S Paulous, F Clavel, et al.Virology|May 1, 1996
Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturationC Quillent, A M Borman, S Paulous, et al.Journal of Virology|December 16, 1998
Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitorsA Dulioust, S Paulous, L Guillemot, et al.Pageof 2